• SPX
  • $5,995.54
  • 0.38 %
  • $22.44
  • DJI
  • $43,988.99
  • 0.59 %
  • $259.65
  • N225
  • $39,533.32
  • 0.08 %
  • $32.95
  • FTSE
  • $8,138.43
  • 0.82 %
  • $66.04
  • IXIC
  • $19,286.78
  • 0.09 %
  • $17.32
Immix Biopharma, Inc. (IMMX) Earning

Immix Biopharma, Inc. (IMMX) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$1.86

$0.11

(6.29%)

Day's range
$1.7
Day's range
$1.94

Immix Biopharma, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.15 -$0.15 -$0.15
Q2 2024 1 -$0.16 -$0.16 -$0.16
Q3 2024 1 -$0.14 -$0.14 -$0.14
Q1 2025 1 -$0.13 -$0.13 -$0.13
Q2 2025 1 -$0.14 -$0.14 -$0.14
Q3 2025 1 -$0.13 -$0.13 -$0.13
Q4 2025 1 -$0.12 -$0.12 -$0.12

Immix Biopharma, Inc. Earnings Date And Information

Immix Biopharma, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.21 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immix Biopharma, Inc. has generated $-1 earnings per share over the last year ($-0.89 diluted earnings per share) and currently has a price-to-earnings ratio of -2.81. Immix Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based on prior year's report dates.

Immix Biopharma, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/12/2024 Q2 2024 -$0.21 -$0.15 0.06 $0 $0
05/09/2024 Q1 2024 -$0.23 -$0.22 0.01 $0
03/29/2024 Q4 2023 -$0.23 -$0.26 -0.03 $4,784
11/09/2023 Q3 2023 -$0.23 $0
08/11/2023 Q2 2023 -$0.17 -$0.24 -0.07 $0
05/12/2023 Q1 2023 -$0.14 -$0.18 -0.04 $0
03/27/2023 Q4 2022 $0.22 -$0.29 -0.51 $-89,517,000
11/09/2022 Q3 2022 -$0.11 $0
08/12/2022 Q2 2022 -$0.11 $0
05/13/2022 Q1 2022 -$0.10 $0
03/28/2022 Q4 2021 -$3.00 $0
09/29/2021 Q3 2021 -$0.06 $0
06/29/2021 Q2 2021 -$0.02 $0
03/30/2021 Q1 2021 -$0.12 $0
12/30/2020 Q4 2020 -$0.10 $0
09/29/2020 Q3 2020 -$0.02 $0
06/29/2020 Q2 2020 -$0.04 $0
03/30/2020 Q1 2020 -$0.04 $0
 

Immix Biopharma, Inc. Earnings: Frequently Asked Questions

  • When is Immix Biopharma, Inc.'s earnings date?

    Immix Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based off last year's report dates.

  • Did Immix Biopharma, Inc. beat their earnings estimates last quarter?

    In the previous quarter, Immix Biopharma, Inc. (:IMMX) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.21 by $0.06.

  • How can I listen to Immix Biopharma, Inc.'s earnings conference call?

    The conference call for Immix Biopharma, Inc.'s latest earnings report can be listened to online.

  • How can I read Immix Biopharma, Inc.'s conference call transcript?

    The conference call transcript for Immix Biopharma, Inc.'s latest earnings report can be read online.

  • How much profit does Immix Biopharma, Inc. generate each year?

    Immix Biopharma, Inc. (:IMMX) has a recorded net income of $0. Immix Biopharma, Inc. has generated $-0.89 earnings per share over the last four quarters.

  • What is Immix Biopharma, Inc.'s price-to-earnings ratio?

    Immix Biopharma, Inc. (:IMMX) has a price-to-earnings ratio of -2.81 and price/earnings-to-growth ratio is -0.3.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.